Molina Healthcare grants Francis S. Soistman Jr. 304 shares

Each director’s annual equity award was set at $220,000, with one quarter granted on the first day of each quarter.

Rhea-AI Filing Summary

Molina Healthcare, Inc. director Francis S. Soistman Jr. received a grant of 304 common shares on October 1, 2026, under the 2025 Equity Incentive Plan. The $55,000 quarterly award was based on the common stock’s $180.85 closing price that day; his direct holdings after the grant were 1,211 shares.

Insider Trade Summary

Grant/Award: 304 shares

Grant/Award 1 txn

Insider SOISTMAN FRANCIS S JR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2, F3	304	$180.85	$55K

Holdings After Transaction: Common Stock — 1,211 shares (Direct)

Footnotes (3)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.
3. F3. Represents the closing price of the Issuer's common stock on October 1, 2026.

Key Figures

Shares granted: 304 shares Closing price: $180.85 per share Direct holdings after grant: 1,211 shares +2 more

5 metrics

Shares granted 304 shares Common stock granted to Francis S. Soistman Jr. on October 1, 2026

Closing price $180.85 per share Common stock closing price on October 1, 2026, used to determine the grant

Direct holdings after grant 1,211 shares Francis S. Soistman Jr.’s reported holdings following the grant

Annual equity award $220,000 Award set for each director

Quarterly equity award $55,000 One quarter of each director’s annual equity award

Key Terms

2025 Equity Incentive Plan, annual equity award, aggregate dollar value

3 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan"

annual equity award financial

"aggregate dollar value of the annual equity award"

aggregate dollar value financial

"The aggregate dollar value of the annual equity award"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did MOH director Francis S. Soistman Jr. receive?

Francis S. Soistman Jr. received a grant of 304 common shares on October 1, 2026. The grant was based on the common stock’s closing price of $180.85 per share, and he held 1,211 shares directly after the grant.

What was the MOH director share grant part of?

The grant was part of the director equity award under the 2025 Equity Incentive Plan. Each director’s annual award was set at $220,000, with $55,000 granted on the first day of each quarter based on the common stock’s closing price that day.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 04:46 PM Accepted by SEC EDGAR 10/02/2026 - 04:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SOISTMAN FRANCIS S JR

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2026		A(1)		304(2)	A	$180.85(3)	1,211	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.

3. Represents the closing price of the Issuer's common stock on October 1, 2026.

Remarks:

	Jeff D. Barlow, power of attorney for Francis Soistman	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)